| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 8e-06 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |